These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
286 related articles for article (PubMed ID: 9989339)
1. The pharmacokinetic principles behind scaling from preclinical results to phase I protocols. Mahmood I; Balian JD Clin Pharmacokinet; 1999 Jan; 36(1):1-11. PubMed ID: 9989339 [TBL] [Abstract][Full Text] [Related]
2. Interspecies scaling: predicting volumes, mean residence time and elimination half-life. Some suggestions. Mahmood I J Pharm Pharmacol; 1998 May; 50(5):493-9. PubMed ID: 9643442 [TBL] [Abstract][Full Text] [Related]
3. Prediction of clearance, volume of distribution and half-life by allometric scaling and by use of plasma concentrations predicted from pharmacokinetic constants: a comparative study. Mahmood I J Pharm Pharmacol; 1999 Aug; 51(8):905-10. PubMed ID: 10504028 [TBL] [Abstract][Full Text] [Related]
4. Interspecies scaling and comparisons in drug development and toxicokinetics. Ings RM Xenobiotica; 1990 Nov; 20(11):1201-31. PubMed ID: 2275215 [TBL] [Abstract][Full Text] [Related]
5. Interspecies scaling: predicting pharmacokinetic parameters of antiepileptic drugs in humans from animals with special emphasis on clearance. Mahmood I; Balian JD J Pharm Sci; 1996 Apr; 85(4):411-4. PubMed ID: 8901079 [TBL] [Abstract][Full Text] [Related]
6. Interspecies allometric analysis of the comparative pharmacokinetics of 44 drugs across veterinary and laboratory animal species. Riviere JE; Martin-Jimenez T; Sundlof SF; Craigmill AL J Vet Pharmacol Ther; 1997 Dec; 20(6):453-63. PubMed ID: 9430769 [TBL] [Abstract][Full Text] [Related]
7. Application of allometric principles for the prediction of pharmacokinetics in human and veterinary drug development. Mahmood I Adv Drug Deliv Rev; 2007 Sep; 59(11):1177-92. PubMed ID: 17826864 [TBL] [Abstract][Full Text] [Related]
8. Allometric issues in drug development. Mahmood I J Pharm Sci; 1999 Nov; 88(11):1101-6. PubMed ID: 10564055 [TBL] [Abstract][Full Text] [Related]
9. Towards a better prediction of peak concentration, volume of distribution and half-life after oral drug administration in man, using allometry. Sinha VK; Vaarties K; De Buck SS; Fenu LA; Nijsen M; Gilissen RA; Sanderson W; Van Uytsel K; Hoeben E; Van Peer A; Mackie CE; Smit JW Clin Pharmacokinet; 2011 May; 50(5):307-18. PubMed ID: 21456631 [TBL] [Abstract][Full Text] [Related]
10. Prediction of Clearance, Volume of distribution, and Half-life of Drugs in Extremely Low to Low Birth Weight Neonates: An Allometric Approach. Mahmood I Eur J Drug Metab Pharmacokinet; 2017 Aug; 42(4):601-610. PubMed ID: 27562171 [TBL] [Abstract][Full Text] [Related]
11. PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 3: comparative assessement of prediction methods of human clearance. Ring BJ; Chien JY; Adkison KK; Jones HM; Rowland M; Jones RD; Yates JW; Ku MS; Gibson CR; He H; Vuppugalla R; Marathe P; Fischer V; Dutta S; Sinha VK; Björnsson T; Lavé T; Poulin P J Pharm Sci; 2011 Oct; 100(10):4090-110. PubMed ID: 21541938 [TBL] [Abstract][Full Text] [Related]
12. Prediction of the pharmacokinetic parameters of reduced-dolasetron in man using in vitro-in vivo and interspecies allometric scaling. Sanwald-Ducray P; Dow J Xenobiotica; 1997 Feb; 27(2):189-201. PubMed ID: 9058532 [TBL] [Abstract][Full Text] [Related]
13. The application of allometric scaling principles to predict pharmacokinetic parameters across species. Huang Q; Riviere JE Expert Opin Drug Metab Toxicol; 2014 Sep; 10(9):1241-53. PubMed ID: 24984569 [TBL] [Abstract][Full Text] [Related]
14. Allometric scaling of pharmacokinetic parameters in drug discovery: can human CL, Vss and t1/2 be predicted from in-vivo rat data? Caldwell GW; Masucci JA; Yan Z; Hageman W Eur J Drug Metab Pharmacokinet; 2004; 29(2):133-43. PubMed ID: 15230342 [TBL] [Abstract][Full Text] [Related]
15. Modelling concentrations of antimicrobial drugs: comparative pharmacokinetics of cephalosporin antimicrobials and accuracy of allometric scaling in food-producing and companion animals. Taverne FJ; van Geijlswijk IM; Heederik DJ; Wagenaar JA; Mouton JW BMC Vet Res; 2016 Sep; 12(1):185. PubMed ID: 27596044 [TBL] [Abstract][Full Text] [Related]
16. Predicting oral clearance in humans: how close can we get with allometry? Sinha VK; De Buck SS; Fenu LA; Smit JW; Nijsen M; Gilissen RA; Van Peer A; Lavrijsen K; Mackie CE Clin Pharmacokinet; 2008; 47(1):35-45. PubMed ID: 18076217 [TBL] [Abstract][Full Text] [Related]
17. A comparative study of allometric scaling with plasma concentrations predicted by species-invariant time methods. Mahmood I; Yuan R Biopharm Drug Dispos; 1999 Apr; 20(3):137-44. PubMed ID: 10211866 [TBL] [Abstract][Full Text] [Related]
18. Interspecies scaling: role of protein binding in the prediction of clearance from animals to humans. Mahmood I J Clin Pharmacol; 2000 Dec; 40(12 Pt 2):1439-46. PubMed ID: 11185664 [TBL] [Abstract][Full Text] [Related]
19. Interspecies scaling: prediction of human biliary clearance and comparison with QSPKR. Morris ME; Yang X; Gandhi YA; Bhansali SG; Benincosa LJ Biopharm Drug Dispos; 2012 Jan; 33(1):1-14. PubMed ID: 22170504 [TBL] [Abstract][Full Text] [Related]
20. Prediction of propofol clearance in children from an allometric model developed in rats, children and adults versus a 0.75 fixed-exponent allometric model. Peeters MY; Allegaert K; Blussé van Oud-Alblas HJ; Cella M; Tibboel D; Danhof M; Knibbe CA Clin Pharmacokinet; 2010 Apr; 49(4):269-75. PubMed ID: 20214410 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]